Join the 'Intraocular Hypertension' group to help and get support from people like you.
Intraocular Hypertension News
FDA Approves Xelpros (latanoprost ophthalmic emulsion) to Treat Open-angle Glaucoma or Ocular Hypertension
Posted 14 Sep 2018 by Drugs.com
MUMBAI, India & PRINCETON, N.J.--(BUSINESS WIRE) September 14, 2018 --Sun Pharmaceutical Industries Ltd. and Sun Pharma Advanced Research Company Ltd. (SPARC) today announced U.S. Food and Drug Administration (USFDA) approval for the New Drug Application (NDA) of Xelpros (latanoprost ophthalmic emulsion) 0.005% for the reduction of elevated intraocular pressure (IOP, or pressure inside the eye) ...
Aerie Pharmaceuticals Announces U.S. FDA Approval of Rhopressa (netarsudil ophthalmic solution) 0.02% for Patients with Open-Angle Glaucoma or Ocular Hypertension
Posted 19 Dec 2017 by Drugs.com
IRVINE, Calif.--(BUSINESS WIRE)--Dec. 18, 2017-- Aerie Pharmaceuticals, Inc. (NASDAQ:AERI) (Aerie or the Company), an ophthalmic pharmaceutical company focused on the discovery, development, and commercialization of first-in-class therapies for the treatment of patients with open-angle glaucoma and other diseases of the eye, today announced that the U.S. Food and Drug Administration (FDA) has ...
Posted 2 Mar 2016 by Drugs.com
WEDNESDAY, March 2, 2016 – A popular "app" that uses your smartphone to check your blood pressure is inaccurate, missing high blood pressure readings in four out of every five patients tested, researchers report. Instant Blood Pressure promises to provide an estimated blood pressure reading if users place their smartphone on the left side of their chest while placing their index finger on the ...
Posted 7 Aug 2015 by Drugs.com
FRIDAY, Aug. 7, 2015 – Pharmacists can play an important role in helping patients control high blood pressure, a new study finds. Researchers followed 625 racially and ethnically diverse Americans with uncontrolled high blood pressure who were seen at 32 medical offices in 15 states. The patients were either cared for by a doctor only, or by a medical team that included a pharmacist. "Clinical ...
Alcon Announces FDA Approval of Simbrinza Suspension, a New Beta Blocker-Free, Fixed-Combination Therapy for Glaucoma Patients
Posted 23 Apr 2013 by Drugs.com
Basel, April 19, 2013 – Alcon, the global leader in eye care and a division of Novartis, announces US FDA approval for Simbrinza Suspension, indicated for the reduction of elevated intraocular pressure (IOP) in patients with primary open-angle glaucoma or ocular hypertension.4 Elevated IOP is the only modifiable risk factor for glaucoma. Glaucoma is a group of eye diseases that lead to ...
Related Condition Support Groups
Related Drug Support Groups
Travatan, Lumigan, Xalatan, latanoprost, Travatan Z, Alphagan, Combigan, Cosopt, Azopt, view more... brimonidine, Alphagan P, dorzolamide, Zioptan, Timoptic, Trusopt, Simbrinza, travoprost, Rhopressa, brinzolamide, Pilopine-HS, Timoptic Ocudose, Betagan, Xelpros, dipivefrin, carbachol, Rescula, Pilostat, Akarpine, Piloptic-2, Piloptic-3, Piloptic-4, Piloptic-6, Timoptic-XE, Betimol, Qoliana, Izba, Cosopt PF, Betoptic, Betoptic-S, Ocupress, AK-Beta, Piloptic-1, bimatoprost, Piloptic-1 / 2, OptiPranolol, dorzolamide / timolol, levobunolol, metipranolol, unoprostone, brimonidine / timolol, tafluprost, brimonidine / brinzolamide, netarsudil, Propine, Isopto Carpine, Ocusert, Pilocar, Istalol, Carbastat, Miostat, Isopto Carbachol, AK-Pro, Betagan C-Cap, Adsorbocarpine, Pilagan with C Cap, Ocu-Carpine, Carboptic